Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypercoagulability syndromes.

R H Thomas1

  • 1Department of General Medicine, University of Miami School of Medicine, 1475 NW 12th Ave, Third Floor, Miami, FL 33136, USA. rthomas@exhcg.com

Archives of Internal Medicine
|December 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid switching from levetiracetam to brivaracetam in pharmaco-resistant epilepsy in people with and without intellectual disabilities: a naturalistic case control study.

Journal of neurology·2023
Same author

Tannate of Quinine.

The North-Western medical and surgical journal·2023
Same author

Letter to the Editor: Sentinel lymph node biopsy in melanoma: Which hot nodes should be harvested and is blue dye really necessary?

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2019
Same author

Testing new treatments for paediatric epilepsies.

Journal of neurology·2015
Same author

Hyperconnectivity in juvenile myoclonic epilepsy: a network analysis.

NeuroImage. Clinical·2015
Same author

Ethnicity can predict GLRA1 genotypes in hyperekplexia.

Journal of neurology, neurosurgery, and psychiatry·2014
Same journal

Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

Archives of internal medicine·2017
Same journal

Occult Carbon Monoxide Poisoning-Reply.

Archives of internal medicine·2017
Same journal

Acquired Immune Deficiency Syndrome-Reply.

Archives of internal medicine·2017
Same journal

Heparin Side Effects-Reply.

Archives of internal medicine·2017
Same journal

Humanizing primary care medicine begins with stress.

Archives of internal medicine·2017
Same journal

Legend omitted and number misrepresented.

Archives of internal medicine·2013
See all related articles

Hypercoagulability, a tendency for thrombosis due to molecular defects, can now be diagnosed in 80-90% of patients. Identifying the cause guides treatment and allows for family screening and early cancer detection.

Area of Science:

  • Internal Medicine
  • Hematology
  • Genetics

Background:

  • Hypercoagulability, characterized by a tendency for thrombosis, stems from inherited or acquired molecular defects.
  • Clinical outcomes of hypercoagulability syndromes can be severe, including potentially lethal thrombotic events.
  • Significant advancements in the last two decades have elucidated the origins of many hypercoagulability syndromes.

Purpose of the Study:

  • To provide internists with a structured approach for identifying hypercoagulability syndromes.
  • To guide the effective treatment strategies for thrombosis associated with hypercoagulability.
  • To highlight the diagnostic and therapeutic implications of uncovering the underlying causes of hypercoagulability.

Main Methods:

  • Review of current literature on hypercoagulability syndromes.

Related Experiment Videos

  • Analysis of diagnostic approaches for identifying molecular defects.
  • Evaluation of treatment strategies based on identified causes.

    • Main Results:

    • Hypercoagulability disorders are diagnosable in 80% to 90% of affected patients.
    • Identifying the specific cause of hypercoagulability influences treatment type and duration.
    • Diagnosis can lead to the discovery of occult malignancies and genetic defects, enabling targeted interventions and family screening.

    Conclusions:

    • A systematic approach to hypercoagulability is crucial for internists.
    • Accurate diagnosis of hypercoagulability syndromes improves patient outcomes through tailored treatment.
    • Understanding the etiology of hypercoagulability facilitates early detection of associated conditions and preventative measures.